The changing characteristics of atrial fibrillation patients treated with warfarin

Por Putnam, Andrew, Gu, Xiaokui, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Krol, Gregory D., Kaatz, Scott, Froehlich, James B., Barnes, Geoffrey D.
Publicado no J Thromb Thrombolysis (2015)

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinic...

Por Barnes, Geoffrey D., Misirliyan, Sevan, Kaatz, Scott, Jackson, Elizabeth A., Haymart, Brian, Kline-Rogers, Eva, Kozlowski, Jay, Krol, Gregory, Froehlich, James B., Sales, Anne
Publicado no Implement Sci (2017)

SAMe-TT(2)R(2) predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI(2) experience

Por Kataruka, Akash, Kong, Xiaowen, Haymart, Brian, Kline-Rogers, Eva, Almany, Steve, Kozlowski, Jay, Krol, Gregory D, Kaatz, Scott, McNamara, Michael W, Froehlich, James B, Barnes, Geoffrey D
Publicado no Vasc Med (2017)

Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants

Por Schaefer, Jordan K., Sood, Suman L., Haymart, Brian, Gu, Xiaokui, Kong, Xiaowen, Kline-Rogers, Eva, Almany, Steven, Kozlowski, Jay, Krol, Gregory D., Kaatz, Scott, Froehlich, James B., Barnes, Geoffrey D.
Publicado no Blood Adv (2017)